Resveratrol Attenuates High Glucose-Induced Osteoblast Dysfunction via AKT/GSK3β/FYN-Mediated NRF2 Activation.
Saved in:
| Title: | Resveratrol Attenuates High Glucose-Induced Osteoblast Dysfunction via AKT/GSK3β/FYN-Mediated NRF2 Activation. |
|---|---|
| Authors: | Xuan Y; School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan, China., Wang J; School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan, China., Zhang X; School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan, China., Wang J; School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan, China., Li J; School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan, China., Liu Q; School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan, China., Lu G; School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan, China., Xiao M; School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan, China., Gao T; School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan, China., Guo Y; School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan, China., Cao C; School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan, China., Chen O; School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan, China., Wang K; School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan, China., Tang Y; Department of Orthopedic Surgery, The First Affiliated Hospital of Shandong First Medical University, Jinan, China., Gu J; School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan, China. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2022 May 23; Vol. 13, pp. 862618. Date of Electronic Publication: 2022 May 23 (Print Publication: 2022). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1663-9812 |
|---|---|
| DOI: | 10.3389/fphar.2022.862618 |
